News
The acceptance of our results for an oral presentation also represents an important company milestone, as it reflects the scientific interest we have generated, as recognized by the largest global ...
Marseille, France, April 23, 2025 10:00 a.m. ET / 4:00 p.m. CET– ImCheck Therapeutics announced today an oral presentation at the upcoming American Society of Clinical Oncology (ASCO ...
Additionally, two abstracts on another drug, AFM24, in combination with atezolizumab for treating non-small cell lung cancer (NSCLC) have been accepted for poster presentations. The oral ...
will be highlighted in an oral presentation. In addition, a trial-in-progress poster on SUPRAME, the ongoing Phase 3 clinical trial evaluating IMA203 in patients with unresectable or metastatic ...
“We are pleased to have the opportunity to present new data from the Phase 2 OVATION 2 Study of IMNN-001 in an oral presentation at ASCO’s Annual ... such as “may,” “will,” “expect,” “plan,” ...
The Supreme Court on Thursday said it would hear oral arguments for President Donald Trump's plan to end automatic birthright citizenship for individuals born in the U.S. to illegal migrants. Trump's ...
Hogg noted that age isn’t the only factor in the organization’s plan, adding that he thinks the likes of Rep. Jan Schakowsky (D-Ill.) and former House Speaker Nancy Pelosi (D-Calif.) — who are age 80 ...
Don't miss our top stories and need-to-know news everyday in your inbox. GODFREY – Representatives from St. Louis planning firm PGAV Planners gave a presentation at Tuesday’s Godfrey Village ...
Pfizer has axed its oral GLP-1 asset danuglipron after one patient had potential drug-induced liver injury in a phase 1 trial. The setback blows a hole in the Big Pharma’s plans to challenge for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results